Your browser doesn't support javascript.
loading
Radiofrequency Ablation for Adenomyosis.
Dedes, Ioannis; Kolovos, Georgios; Arrigo, Fruscalzo; Toub, David; Vaineau, Cloé; Lanz, Susanne; Imboden, Sara; Feki, Anis; Mueller, Michael D.
Afiliação
  • Dedes I; Department of Obstetrics and Gynecology, University Hospital of Bern, University of Bern, 3010 Bern, Switzerland.
  • Kolovos G; Department of Obstetrics and Gynecology, University Hospital of Bern, University of Bern, 3010 Bern, Switzerland.
  • Arrigo F; Department of Gynecology and Obstetrics, University Hospital of Fribourg, 1752 Fribourg, Switzerland.
  • Toub D; Gynesonics®, Redwood City, CA 94063, USA.
  • Vaineau C; Department of Obstetrics and Gynecology, University Hospital of Bern, University of Bern, 3010 Bern, Switzerland.
  • Lanz S; Department of Obstetrics and Gynecology, University Hospital of Bern, University of Bern, 3010 Bern, Switzerland.
  • Imboden S; Department of Obstetrics and Gynecology, University Hospital of Bern, University of Bern, 3010 Bern, Switzerland.
  • Feki A; Department of Gynecology and Obstetrics, University Hospital of Fribourg, 1752 Fribourg, Switzerland.
  • Mueller MD; Department of Obstetrics and Gynecology, University Hospital of Bern, University of Bern, 3010 Bern, Switzerland.
J Clin Med ; 12(9)2023 Apr 23.
Article em En | MEDLINE | ID: mdl-37176514
ABSTRACT
Adenomyosis is a common benign gynecologic condition characterized by ectopic endometrial glands and stroma in the myometrium causing pain (dysmenorrhea) and abnormal uterine bleeding. New interventional techniques have been introduced over recent years. This study evaluates the treatment success and side effects of radiofrequency ablation. An electronic literature search in the PubMed, Scopus, and ScienceDirect databases was carried out on the outcomes of pain reduction and, secondarily, on abnormal uterine bleeding, reintervention, reproductive outcome, imaging outcome, and complications. There was a mean decrease in dysmenorrhea pain scores by -63.4 ± 9.0% at 12 months. Data on other outcome parameters were sparse. No major complications were reported. Radiofrequency ablation represents a promising minimally invasive and organ-preserving treatment in patients with symptomatic adenomyosis. It is associated with clinically meaningful improvement of adenomyosis-related pain in the short term.
Palavras-chave

Texto completo: 1 Base de dados: MEDLINE Idioma: En Ano de publicação: 2023 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Idioma: En Ano de publicação: 2023 Tipo de documento: Article